Atirmociclib and fulvestrant for patients with HR-positive/HER2-negative advanced or metastatic breast cancer who progressed on a prior cyclin-dependent kinase 4/6 inhibitor: primary analysis of the randomized FourLight-1 trial☆
Publication date: Available online 24 October 2026 Source: Annals of Oncology Author(s): A. Giordano, B. Xu, T. Yoshinami, C.-S. Huang, Y.H. Park, G.L. Lerzo, H. Li, A. Shai, G. Garnica Jaliffe, M. Itoh, A. Williams, S. Goel, S.-A. Im, P. Cobb, M. Golmakani, F. Liu, R.A. Moss, A. Vana, M. Ignatiadis, H.S. Rugo
Atirmociclib and fulvestrant for patients with HR-positive/HER2-negative advanced or metastatic breast cancer who progressed on a prior cyclin-dependent kinase 4/6 inhibitor: primary analysis of the randomized FourLight-1 trial☆. // Annals of Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S0923753426080749?dgcid=rss_sd_all
Atirmociclib and fulvestrant for patients with HR-positive/HER2-negative advanced or metastatic breast cancer who progressed on a prior cyclin-dependent kinase 4/6 inhibitor: primary analysis of the randomized FourLight-1 trial☆. Annals of Oncology. https://www.sciencedirect.com/science/article/pii/S0923753426080749?dgcid=rss_sd_all
“Atirmociclib and fulvestrant for patients with HR-positive/HER2-negative advanced or metastatic breast cancer who progressed on a prior cyclin-dependent kinase 4/6 inhibitor: primary analysis of the randomized FourLight-1 trial☆.” Annals of Oncology.
@article{article36266,
title = {Atirmociclib and fulvestrant for patients with HR-positive/HER2-negative advanced or metastatic breast cancer who progressed on a prior cyclin-dependent kinase 4/6 inhibitor: primary analysis of the randomized FourLight-1 trial☆},
journal = {Annals of Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S0923753426080749?dgcid=rss_sd_all}
}
ABSTRACT Diagnosing and classifying platelet disorders (PD) is challenging in children. Therefore, we evaluated clinical, laboratory, and genetic data to improve current algorithms by performing a prospective observational cohort study...
Abstract Background and Objectives Perioperative blood transfusion in hip arthroplasty is associated with increased morbidity, prolonged hospitalization, and higher costs. This study aimed to identify independent risk factors and...